Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expanding and improving nanobody repertoires using a yeast display method: Targeting SARS-CoV-2
Frederick R. Cross, Peter C. Fridy, Natalia E. Ketaren, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 3, pp. 102954-102954
Open Access | Times Cited: 17

Showing 17 citing articles:

Discovery of nanobodies: a comprehensive review of their applications and potential over the past five years
Elena Alexander, Kam W. Leong
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Nanoscale warriors against viral invaders: a comprehensive review of Nanobodies as potential antiviral therapeutics
Vaishali Verma, N. D. Sinha, A. Raja
mAbs (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
Yang Yang, Fang Li, Lanying Du
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
A new strategy to generate nanobodies for the coumaphos based on the synthesized nanobody libraries
Ru-Yu Fang, Yingxue Li, Fei Liu, et al.
Food Chemistry (2024) Vol. 455, pp. 139684-139684
Closed Access | Times Cited: 4
The Use of Heterologous Antigens for Biopanning Enables the Selection of Broadly Neutralizing Nanobodies Against SARS-CoV-2
V. S. Aripov, Anna V. Zaykovskaya, Ludmila V. Mechetina, et al.
Antibodies (2025) Vol. 14, Iss. 1, pp. 23-23
Open Access
Advancements in nanobody-based immunodiagnostics and infectious pathogens, foodborne hazards, and human biomarkers
Yawen Liu, Jiajie Liu, Z. Q. Qiu, et al.
Microchemical Journal (2025), pp. 114083-114083
Closed Access
Molecular Evolution of Antiparathion Nanobody with Enhanced Sensitivity and Specificity Based on Structural Analysis
Jiadong Li, Xing Shen, Zhenlin Xu, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 40, pp. 14758-14768
Closed Access | Times Cited: 9
Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus
Natalia E. Ketaren, Fred D. Mast, Peter C. Fridy, et al.
eLife (2024) Vol. 12
Open Access | Times Cited: 3
Nanobodies: from high-throughput identification to therapeutic development
Peter C. Fridy, Michael P. Rout, Natalia E. Ketaren
Molecular & Cellular Proteomics (2024), pp. 100865-100865
Open Access | Times Cited: 3
A new generation of nanobody research tools using improved mass spectrometry-based discovery methods
Peter C. Fridy, Ryan Farrell, Kelly R. Molloy, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 9, pp. 107623-107623
Open Access | Times Cited: 2
Quantitative flow cytometric selection of tau conformational nanobodies specific for pathological aggregates
Jennifer M. Zupancic, Matthew D. Smith, Hanna Trzeciakiewicz, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus
Natalia E. Ketaren, Fred D. Mast, Peter C. Fridy, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 1
Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus
Natalia E. Ketaren, Fred D. Mast, Peter C. Fridy, et al.
(2023)
Open Access | Times Cited: 1
Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus
Natalia E. Ketaren, Fred D. Mast, Peter C. Fridy, et al.
(2024)
Open Access
Optimized single-cell gates for yeast display screening
Xiaoli Pan, Matheus Oliveira de Souza, Francisco M Figueiras, et al.
Protein Engineering Design and Selection (2024) Vol. 38
Closed Access
Backstage Heroes—Yeast in COVID-19 Research
Wojciech Grabiński, Andonis Karachitos, Anna Kicińska
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12661-12661
Open Access
Quantitative flow cytometric selection of tau conformational nanobodies specific for pathological aggregates
Jennifer M. Zupancic, Matthew D. Smith, Hanna Trzeciakiewicz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus
Natalia E. Ketaren, Fred D. Mast, Peter C. Fridy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top